Entrée Health PT retweeted
I Am Patient and Staying at Home. So should you #IAmPatient #StayHome #BePatient #COVID bddy.me/3boV5BY
Entrée Health PT retweeted
Join the discussion on the future of care and #reimbursement for disease states like #diabetes, #COPD and much more with panelists Kurt Hudson, Peter Lynch, @speskin and Mark Vineis at #MMMTransformingHealthcare on May 8 in NYC. bit.ly/2UIKLQp
Honored to be named a 2018 #Manny Vision Award Finalist by @medadnews #mannyawards #ThisWayIn pharmalive.com/med-ad-news-a…
First Blood Test to Assess Concussion in Adults Gets FDA Approval empr.com/traumatic-brain-inj… via @empr
Entrée Health PT retweeted
Saying that something only takes a minute undermines your skills and gives the impression that you rush through tasks...11 Things Smart People Won't Say At Work via @forbes forbes.com/sites/travisbradb…
Big news for healthcare. Curious to see how this progresses. Amazon, Berkshire Hathaway and JPMorgan Team Up to Disrupt Health Care nyti.ms/2FtFYr1
Entrée Health PT retweeted
ChatBot campaign for flu shot bolsters patient response by 30%
healthcareitnews.com/news/ch…
Entrée Health PT retweeted
New IPA research debunks myths on millennials’ medicine habits @The_IPA advertisinghealth.co.uk/new-…
Wow. Creative dedication. xitter.cf/alexwhitcomb/status/95…
Inspiration for our art friends “Challenge: To create an illustration style” by @alpower81 medium.com/qstream-design/ch…
Doctors And Hospitals Say ‘Show Me The Money’ Before Treating Patients californiahealthline.org/MjE… via @CalHealthline
Entrée Health PT retweeted
As we welcome in the new year, @KetchumPR's newly minted CEO, @barrirafferty, shares her advice on leadership and #talent cultivation bit.ly/2lRpJML
New drug approvals in the U.S. more than doubled in 2017 fastcompany.com/40512495/new…
Great people work here! :) xitter.cf/OHGTalent/status/84748…
60 seconds with Daniel Brennan: Account Executive at CDM NY!: youtu.be/ABJ3GmgsQMs?a via @YouTube
Oncology costs continue to grow - 11.5% growth in spend #AMCP2017
Expect increased price transparency and a shift away from deep rebates #AMCP2017
Public option putting pressure on PBMs and manufactures #AMCP2017















